Mabvax Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Mabvax Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Mabvax Therapeutics (United States)?

ScholarIQrecord summary

Mabvax Therapeutics (United States) is a research organisation in San Diego, United States. OpenAlex records 66 works and 1,880 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Mabvax Therapeutics (United States) have?

ScholarIQindexed works

Mabvax Therapeutics (United States) has 66 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Mabvax Therapeutics (United States) →

How many citations does Mabvax Therapeutics (United States) have?

ScholarIQcitation count

Mabvax Therapeutics (United States) has 1,880 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Mabvax Therapeutics (United States) →

How many researchers are at Mabvax Therapeutics (United States)?

ScholarIQresearcher count

Mabvax Therapeutics (United States) has 1 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Mabvax Therapeutics (United States)?

ScholarIQavg h-index

Mabvax Therapeutics (United States) has an average h-index of 62 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Mabvax Therapeutics (United States)?

ScholarIQror

The ROR for Mabvax Therapeutics (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Mabvax Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for Mabvax Therapeutics (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Mabvax Therapeutics (United States)?

ScholarIQtop researchers by citations

Robert H. Pierce · Cancer Immunotherapy and Biomarkers

314 works22,702 citations

What are the most-cited papers on Mabvax Therapeutics (United States)?

ScholarIQmost cited works

Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer

Yongwoo David Seo, Xiuyun Jiang, Kevin M. Sullivan, Florencia G. Jalikis, Kimberly S. Smythe, Arezou Abbasi, Marissa Vignali, James O. Park, Sara K. Daniel, Seth M. Pollack, Teresa S. Kim, Raymond S. Yeung, Ian Nicholas Crispe, Robert H. Pierce, Harlan Robins, Venu G. Pillarisetty

Clinical Cancer Research. 2019229 CitationsOPEN ACCESS

Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial

Shihong Zhang, Karan Kohli, Graeme Black, Yao Lu, Sydney M. Spadinger, Qianchuan He, Venu G. Pillarisetty, Lee D. Cranmer, Brian A. Van Tine, Cassian Yee, Robert H. Pierce, Stanley R. Riddell, Robin L. Jones, Seth M. Pollack

Cancer Immunology Research. 2019165 CitationsOPEN ACCESS

How much of the research on Mabvax Therapeutics (United States) is open access?

ScholarIQopen access share

100%OPEN ACCESS

Gold

Green

Hybrid

Bronze

100%

Closed